{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:12:32Z","timestamp":1787951552037,"version":"build-2784847793"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["120 S225"],"award-info":[{"award-number":["120 S225"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nut.2022.111742","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T01:38:46Z","timestamp":1653269926000},"page":"111742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Inulin may prevent steatosis by suppressing cannabinoid receptor-1 and patatin-like phospholipase-3 expression in liver"],"prefix":"10.1016","volume":"103-104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7089-6840","authenticated-orcid":false,"given":"\u0130smail M\u00fccahit","family":"Alptekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda P\u0131nar","family":"\u00c7ak\u0131ro\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Kiremitci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"Re\u00e7ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emirhan","family":"Nemutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2022.111742_bib0001","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4162\/nrp.2015.9.4.350","article-title":"Characteristics of nonalcoholic fatty liver disease induced in Wistar rats following four different diets","volume":"9","author":"Fakhoury-Sayegh","year":"2015","journal-title":"Nutr Res Pract"},{"key":"10.1016\/j.nut.2022.111742_bib0002","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Nonalcoholic Steatohepatitis Clinical Research Network. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2022.111742_bib0003","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nut.2022.111742_bib0004","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/nu9101072","article-title":"Animal models of nonalcoholic fatty liver disease\u2014a starter's guide","volume":"9","author":"Van Herck","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2022.111742_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: that we need in the future","volume":"38","author":"Ara\u00fajo","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.nut.2022.111742_bib0006","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.nut.2022.111742_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43440-019-00020-1","article-title":"New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis","volume":"72","author":"Pydyn","year":"2020","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.nut.2022.111742_bib0008","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2022.111742_bib0009","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.nut.2022.111742_bib0010","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1038\/s41598-020-66241-0","article-title":"Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools","volume":"10","author":"Lang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nut.2022.111742_bib0011","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nut.2006.09.004","article-title":"Dietary habits and nutrient intake in non-alcoholic steatohepatitis","volume":"23","author":"Toshimitsu","year":"2007","journal-title":"Nutrition"},{"key":"10.1016\/j.nut.2022.111742_bib0012","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.nut.2022.111742_bib0013","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3748\/wjg.v16.i18.2223","article-title":"Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease","volume":"16","author":"Basaranoglu","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nut.2022.111742_bib0014","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2022.111742_bib0015","doi-asserted-by":"crossref","first-page":"17078","DOI":"10.3390\/molecules191117078","article-title":"Endocannabinoids, related compounds and their metabolic routes","volume":"19","author":"Fezza","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.nut.2022.111742_bib0016","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1096\/fj.06-7717com","article-title":"The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species","volume":"21","author":"Siegmund","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.nut.2022.111742_bib0017","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/liv.12263","article-title":"The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives","volume":"33","author":"Baldassarre","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.nut.2022.111742_bib0018","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/oby.21687","article-title":"Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease","volume":"25","author":"Zelber-Sagi","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.nut.2022.111742_bib0019","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/ijms20102516","article-title":"Endocannabinoid system in hepatic glucose metabolism, fatty liver disease, and cirrhosis","volume":"20","author":"Bazwinsky-Wutschke","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nut.2022.111742_bib0020","doi-asserted-by":"crossref","first-page":"33302","DOI":"10.1038\/srep33302","article-title":"Human CB1 receptor isoforms, present in hepatocytes and \u03b2-cells, are involved in regulating metabolism","volume":"6","author":"Gonz\u00e1lez-Mariscal","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nut.2022.111742_bib0021","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1016\/j.bmcl.2013.06.066","article-title":"Peripherally restricted CB1 receptor blockers","volume":"23","author":"Chorvat","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nut.2022.111742_bib0022","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/oby.22964","article-title":"A fad too far? Dietary strategies for the prevention and treatment of NAFLD","volume":"28","author":"Moore","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.nut.2022.111742_bib0023","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1743-7075-11-36","article-title":"Different types of soluble fermentable dietary fibre decrease food intake, body weight gain and adiposity in young adult male rats","volume":"11","author":"Adam","year":"2014","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.nut.2022.111742_bib0024","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S0954422410000089","article-title":"Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation","volume":"23","author":"Sleeth","year":"2010","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.nut.2022.111742_bib0025","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1467-789X.2011.00895.x","article-title":"Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials","volume":"12","author":"Wanders","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.nut.2022.111742_bib0026","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12986-015-0033-2","article-title":"A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes","volume":"12","author":"Guess","year":"2015","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.nut.2022.111742_bib0027","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12876-015-0400-5","article-title":"Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol","volume":"15","author":"Lambert","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.nut.2022.111742_bib0028","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/nu8070397","article-title":"Beneficial effect of synbiotic supplementation on hepatic steatosis and anthropometric parameters, but not on gut permeability in a population with nonalcoholic steatohepatitis","volume":"8","author":"Ferolla","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.nut.2022.111742_bib0029","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1038\/nutd.2015.35","article-title":"The application of omics technologies in the functional evaluation of inulin and inulin-containing prebiotics dietary supplementation","volume":"5","author":"Tsurumaki","year":"2015","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.nut.2022.111742_bib0030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jnutbio.2015.03.010","article-title":"Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice","volume":"26","author":"Weitkunat","year":"2015","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nut.2022.111742_bib0031","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1743-7075-9-23","article-title":"Effects of dietary inulin, statin, and their co-treatment on hyperlipidemia, hepatic steatosis and changes in drug-metabolizing enzymes in rats fed a high-fat and high-sucrose diet","volume":"9","author":"Sugatani","year":"2012","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.nut.2022.111742_bib0032","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1124\/dmd.106.010645","article-title":"Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression","volume":"34","author":"Sugatani","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nut.2022.111742_bib0033","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00394-008-0713-z","article-title":"Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and high-sucrose (cafeteria) diet","volume":"47","author":"Sugatani","year":"2008","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.nut.2022.111742_bib0034","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1478-3231.2011.02730.x","article-title":"The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance","volume":"32","author":"Parnell","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.nut.2022.111742_bib0035","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2022.111742_bib0036","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2020.00218","article-title":"Hepatoprotective effect of cranberry nutraceutical extract in non-alcoholic fatty liver model in rats: impact on insulin resistance and NRF-2 expression","volume":"11","author":"Faheem","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nut.2022.111742_bib0037","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5439","article-title":"Purification of RNA using TRIzol (TRI reagent)","author":"Rio","year":"2010","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.nut.2022.111742_bib0038","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.nut.2022.111742_bib0039","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exphem.2017.09.009","article-title":"Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation","volume":"57","author":"K\u00f6se","year":"2018","journal-title":"Exp Hematol"},{"key":"10.1016\/j.nut.2022.111742_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1476-511X-13-173","article-title":"Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model","volume":"13","author":"Shi","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.nut.2022.111742_bib0041","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nut.2022.111742_bib0042","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","article-title":"Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice","volume":"118","author":"Osei-Hyiaman","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nut.2022.111742_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206152","article-title":"CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes","volume":"13","author":"Chang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2022.111742_bib0044","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1208\/s12248-010-9178-0","article-title":"Role of cannabinoids in the development of fatty liver (steatosis)","volume":"12","author":"Purohit","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.nut.2022.111742_bib0045","first-page":"47","article-title":"Mechanistic potential and therapeutic implications of cannabinoids in nonalcoholic fatty liver disease","volume":"2","author":"Dibba","year":"2018","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.nut.2022.111742_bib0046","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1002\/fsn3.2283","article-title":"Chain length-dependent inulin alleviates diet-induced obesity and metabolic disorders in mice","volume":"9","author":"Li","year":"2021","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.nut.2022.111742_bib0047","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40168-021-01125-7","article-title":"Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signalling in mice","volume":"9","author":"Aoki","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.nut.2022.111742_bib0048","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1476-5381.2011.01397.x","article-title":"The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings","volume":"163","author":"Mallat","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nut.2022.111742_bib0049","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/db09-1482","article-title":"CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice","volume":"59","author":"Jourdan","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.nut.2022.111742_bib0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2337\/db13-0774","article-title":"Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity","volume":"63","author":"Hyysalo","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.nut.2022.111742_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042259","article-title":"Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease","volume":"7","author":"Rossi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nut.2022.111742_bib0052","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1136\/gutjnl-2019-319726","article-title":"Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients","volume":"69","author":"Rodriguez","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.nut.2022.111742_bib0053","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/hep.26170","article-title":"Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats","volume":"57","author":"Kumashiro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2022.111742_bib0054","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.lfs.2014.06.012","article-title":"Pivotal role of cAMP in the activation of liver glycogen breakdown in high-fat diet fed mice","volume":"109","author":"Schiavon","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.nut.2022.111742_bib0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/biof.1307","article-title":"Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36\/FAT scavenger receptor\/fatty acids transporter gene expression","volume":"43","author":"Zingg","year":"2017","journal-title":"Biofactors"},{"key":"10.1016\/j.nut.2022.111742_bib0056","first-page":"1","article-title":"The role of hepatic transcription factor cAMP response element-binding protein (CREB) during the development of experimental nonalcoholic fatty liver: a biochemical and histomorphometric study","volume":"10","author":"Awaad","year":"2020","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.nut.2022.111742_bib0057","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2022.111742_bib0058","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5101423","article-title":"Effect of inulin-type carbohydrates on insulin resistance in patients with type 2 diabetes and obesity: a systematic review and meta-analysis","volume":"2019","author":"Rao","year":"2019","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.nut.2022.111742_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.558525","article-title":"Inulin exerts beneficial effects on non-alcoholic fatty liver disease via modulating gut microbiome and suppressing the lipopolysaccharide-toll-like receptor 4-m\u03c8-nuclear factor-\u03bab-nod-like receptor protein 3 pathway via gut-liver axis in mice","volume":"11","author":"Bao","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nut.2022.111742_bib0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbrc.2022.02.033","article-title":"Inulin activates FXR-FGF15 signaling and further increases bile acids excretion in non-alcoholic fatty liver disease mice","volume":"600","author":"Wang","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nut.2022.111742_bib0061","article-title":"Adiponectin, leptin, and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD","volume":"8","author":"Marques","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.nut.2022.111742_bib0062","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3748\/wjg.v19.i6.802","article-title":"What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?","volume":"19","author":"Finelli","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nut.2022.111742_bib0063","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/1751-2980.12980","article-title":"Liver and serum adiponectin levels in non-alcoholic fatty liver disease","volume":"22","author":"Mavilia","year":"2021","journal-title":"J Dig Dis"},{"key":"10.1016\/j.nut.2022.111742_bib0064","article-title":"Low levels of spexin and adiponectin may predict insulin resistance in patients with non-alcoholic fatty liver","volume":"24","author":"Zhang","year":"2021","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.nut.2022.111742_bib0065","doi-asserted-by":"crossref","first-page":"E457","DOI":"10.1152\/ajpendo.00489.2013","article-title":"Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity","volume":"306","author":"Tam","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.nut.2022.111742_bib0066","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.nut.2022.111742_bib0067","article-title":"Effects of \u03b2-glucan and inulin consumption on postprandial appetite, energy intake and food consumption in healthy females: a randomized controlled trial","author":"Alptekin","year":"2021","journal-title":"Nutr Health"},{"key":"10.1016\/j.nut.2022.111742_bib0068","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.3748\/wjg.v26.i40.6141","article-title":"Role of gut microbiota via the gut-liver-brain axis in digestive diseases","volume":"26","author":"Ding","year":"2020","journal-title":"World J Gastroenterol"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900722001551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900722001551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:20:59Z","timestamp":1760271659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900722001551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":68,"alternative-id":["S0899900722001551"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2022.111742","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inulin may prevent steatosis by suppressing cannabinoid receptor-1 and patatin-like phospholipase-3 expression in liver","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2022.111742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111742"}}